Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia.
Tigu AB, Constantinescu CS, Teodorescu P, Kegyes D, Munteanu R, Feder R, Peters M, Pralea I, Iuga C, Cenariu D, Marcu A, Tanase A, Colita A, Drula R, Bergthorsson JT, Greiff V, Dima D, Selicean C, Rus I, Zdrenghea M, Gulei D, Ghiaur G, Tomuleasa C. Tigu AB, et al. Among authors: tomuleasa c. J Cell Mol Med. 2023 Oct;27(19):2864-2875. doi: 10.1111/jcmm.17810. Epub 2023 Sep 4. J Cell Mol Med. 2023. PMID: 37667538 Free PMC article.
BCR-ABL1 T315I mutation, a negative prognostic factor for the terminal phase of chronic myelogenous leukemia treated with first- and second-line tyrosine kinase inhibitors, might be an indicator of allogeneic stem cell transplant as the treatment of choice.
Tomuleasa C, Dima D, Frinc I, Patiu M, Petrushev B, Cucuianu A, Berindan-Neagoe I. Tomuleasa C, et al. Leuk Lymphoma. 2015 Feb;56(2):546-7. doi: 10.3109/10428194.2014.940582. Epub 2014 Aug 19. Leuk Lymphoma. 2015. PMID: 25012945 No abstract available.
Magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab.
Dima D, Tomuleasa C, Irimie A, Florian IS, Petrushev B, Berindan-Neagoe I, Cucuianu A. Dima D, et al. Among authors: tomuleasa c. Cancer. 2014 Dec 15;120(24):4005-6. doi: 10.1002/cncr.28948. Epub 2014 Aug 13. Cancer. 2014. PMID: 25123910 Free article. No abstract available.
Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation.
Zaharie F, Cojocneanu-Petric R, Muresan M, Frinc I, Dima D, Petrushev B, Tanase A, Berce C, Chitic M, Berindan-Neagoe I, Pileczki V, Irimie A, Tomuleasa C. Zaharie F, et al. Among authors: tomuleasa c. Int J Nanomedicine. 2015 Jul 31;10:4897-9. doi: 10.2147/IJN.S87405. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26261416 Free PMC article. No abstract available.
213 results